Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) (Q44433279)
Jump to navigation
Jump to search
scientific article published on January 1, 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) |
scientific article published on January 1, 2003 |
Statements
1 reference
Strategic approach to the management of Hodgkin’s disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) (English)
1 reference
Strategic approach to the management of Hodgkin's disease incorporating salvage therapy with high-dose ifosfamide, etoposide and epirubicin: a Northern Region Lymphoma Group study (UK) (English)
1 reference
Northern Region Lymphoma Group
1 reference
S. J. Proctor
G. H. Jackson
A. Lennard
B. Angus
K. Wood
H. L. Lucraft
J. White
K. Windebank
1 January 2003
1 reference
1 reference
1 reference
1 reference
14 Suppl 1
1 reference
i47-50
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference